124 related articles for article (PubMed ID: 102190)
1. Immunologically diagnosed malignancy in Sjögren's pseudolymphoma.
Faguet GB; Webb HH; Agee JF; Ricks WB; Sharbaugh AH
Am J Med; 1978 Sep; 65(3):424-9. PubMed ID: 102190
[TBL] [Abstract][Full Text] [Related]
2. Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm.
Zulman J; Jaffe R; Talal N
N Engl J Med; 1978 Nov; 299(22):1215-20. PubMed ID: 309554
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte phenotype and function in pseudolymphoma associated with Sjögren's syndrome.
Fox RI; Adamson TC; Fong S; Robinson CA; Morgan EL; Robb JA; Howell FV
J Clin Invest; 1983 Jul; 72(1):52-62. PubMed ID: 6603476
[TBL] [Abstract][Full Text] [Related]
4. Nodal and extranodal lymphoproliferative disorders in Sjogren's syndrome: a clinical and immunopathologic study.
McCurley TL; Collins RD; Ball E; Collins RD
Hum Pathol; 1990 May; 21(5):482-92. PubMed ID: 2110929
[TBL] [Abstract][Full Text] [Related]
5. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
[TBL] [Abstract][Full Text] [Related]
6. Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome.
De Vita S; Boiocchi M; Sorrentino D; Carbone A; Avellini C; Dolcetti R; Marzotto A; Gloghini A; Bartoli E; Beltrami CA; Ferraccioli G
Arthritis Rheum; 1997 Feb; 40(2):318-31. PubMed ID: 9041944
[TBL] [Abstract][Full Text] [Related]
7. Small-cell lymphoma and Sjögren's syndrome. Lymphoplasmacytic subvariant of small-cell lymphoma with IgA/kappa immunoglobulin surface markers.
Askari AD; Laqui CC; Rassiga AL; Hogrefe WR; Laipply TC
Arch Intern Med; 1985 May; 145(5):935-7. PubMed ID: 3922321
[TBL] [Abstract][Full Text] [Related]
8. From benign polyclonal to malignant monoclonal lymphoproliferation in a patient with primary Sjögren's syndrome.
Díaz-Jouanen E; Ruíz-Argüelles GJ; Vega-Ortíz JM; Villareal G; Alarcón-Segovia D
Arthritis Rheum; 1981 Jun; 24(6):850-3. PubMed ID: 7018500
[No Abstract] [Full Text] [Related]
9. Widespread clonal B-cell disorder in Sjögren's syndrome predisposing to Helicobacter pylori-related gastric lymphoma.
De Vita S; Ferraccioli G; Avellini C; Sorrentino D; Dolcetti R; Di Loreto C; Bartoli E; Boiocchi M; Beltrami CA
Gastroenterology; 1996 Jun; 110(6):1969-74. PubMed ID: 8964425
[TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative disorders in Sjögren's syndrome.
Masaki Y; Sugai S
Autoimmun Rev; 2004 Mar; 3(3):175-82. PubMed ID: 15110228
[TBL] [Abstract][Full Text] [Related]
11. Low-grade lymphoma of immature T-cell phenotype in a case of lymphocytic interstitial pneumonia and Sjögren's syndrome.
Schuurman HJ; Gooszen HC; Tan IW; Kluin PM; Wagenaar SS; van Unnik JA
Histopathology; 1987 Nov; 11(11):1193-204. PubMed ID: 3500906
[TBL] [Abstract][Full Text] [Related]
12. T cell receptor repertoire in B cell lymphoproliferative lesions in primary Sjögren's syndrome.
Pivetta B; De Vita S; Ferraccioli G; De Re V; Gloghini A; Marzotto A; Caruso G; Dolcetti R; Bartoli E; Carbone A; Boiocchi M
J Rheumatol; 1999 May; 26(5):1101-9. PubMed ID: 10332975
[TBL] [Abstract][Full Text] [Related]
13. The immunologic characterization of 40 extranodal lymphoid infiltrates: usefulness in distinguishing between benign pseudolymphoma and malignant lymphoma.
Knowles DM; Halper JP; Jakobiec FA
Cancer; 1982 Jun; 49(11):2321-35. PubMed ID: 6804083
[TBL] [Abstract][Full Text] [Related]
14. Monotypic plasma cells in labial salivary glands of patients with Sjögren's syndrome: prognosticator for systemic lymphoproliferative disease.
Bodeutsch C; de Wilde PC; Kater L; van den Hoogen FH; Hené RJ; van Houwelingen JC; van de Putte LB; Vooijs GP
J Clin Pathol; 1993 Feb; 46(2):123-8. PubMed ID: 8459032
[TBL] [Abstract][Full Text] [Related]
15. [Sjogren's syndrome and lymphoproliferative lesions].
Sugai S
Nihon Naika Gakkai Zasshi; 2000 Sep; 89(9):1948-56. PubMed ID: 11051677
[No Abstract] [Full Text] [Related]
16. [Pseudolymphoma and lymphoproliferative syndromes in Gougerot-Sjögren syndrome (author's transl)].
Diebold J; Zittoun R; Tulliez M; Reynes M; Tricot G; Bernadou A; Audouin J
Sem Hop; 1978 Oct 18-25; 54(33-36):1033-40. PubMed ID: 220714
[TBL] [Abstract][Full Text] [Related]
17. Preliminary classification of nonmalignant B cell proliferation in Sjögren's syndrome: perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach.
De Vita S; De Marchi G; Sacco S; Gremese E; Fabris M; Ferraccioli G
Blood Cells Mol Dis; 2001; 27(4):757-66. PubMed ID: 11778660
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic implications of mixed monoclonal cryoglobulinemia in Sjogren's disease].
Vasil'ev VI; Probatova NA; Varlamova EIu; Tupitsin NN; Simonova MV; Safonova TN; Bozh'eva LA; Shornikova NS; Logvinenko OA; Belenin GIu
Ter Arkh; 2004; 76(8):61-8. PubMed ID: 15471400
[TBL] [Abstract][Full Text] [Related]
19. B-cell lymphoproliferation in primary Sjögren's syndrome.
Tzioufas AG
Clin Exp Rheumatol; 1996; 14 Suppl 14():S65-70. PubMed ID: 8722203
[TBL] [Abstract][Full Text] [Related]
20. Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands.
Moutsopoulos HM; Tzioufas AG; Bai MK; Papadopoulos NM; Papadimitriou CS
Ann Rheum Dis; 1990 Nov; 49(11):929-31. PubMed ID: 2124096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
